Page last updated: 2024-10-22

amfenac and Facial Pain

amfenac has been researched along with Facial Pain in 1 studies

amfenac: RN given refers to parent cpd; structure
amfenac : An oxo monocarboxylic acid that is benzophenone in which one of the phenyl groups is substituted by an amino group and a carboxymethyl group at position 2 and 3, respectively. The corresponding carboxamide, nepafenac, is a prodrug of amfenac and is used for the treatment of pain and inflammation following cataract surgery.

Facial Pain: Pain in the facial region including orofacial pain and craniofacial pain. Associated conditions include local inflammatory and neoplastic disorders and neuralgic syndromes involving the trigeminal, facial, and glossopharyngeal nerves. Conditions which feature recurrent or persistent facial pain as the primary manifestation of disease are referred to as FACIAL PAIN SYNDROMES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haketa, T1
Kino, K1
Sugisaki, M1
Takaoka, M1
Ohta, T1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Additional Effects of Therapeutic Exercises Under a Behavioral Umbrella for Chronic Temporomandibular Disorders Treatment. A Double-blind Randomized Clinical Trial[NCT03596606]34 participants (Actual)Interventional2019-09-16Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for amfenac and Facial Pain

ArticleYear
Randomized clinical trial of treatment for TMJ disc displacement.
    Journal of dental research, 2010, Volume: 89, Issue:11

    Topics: Activities of Daily Living; Adult; Anti-Inflammatory Agents, Non-Steroidal; Facial Pain; Female; Fol

2010